J 2021

Global Impact of COVID-19 on Stroke Care and IV Thrombolysis

NOGUEIRA, R. G., M. M. QURESHI, M. ABDALKADER, S. O. MARTINS, H. YAMAGAMI et. al.

Basic information

Original name

Global Impact of COVID-19 on Stroke Care and IV Thrombolysis

Authors

NOGUEIRA, R. G., M. M. QURESHI, M. ABDALKADER, S. O. MARTINS, H. YAMAGAMI, Z. M. QIU, O. Y. MANSOUR, A. SATHYA, A. CZLONKOWSKA, G. TSIVGOULIS, D. A. DE SOUSA, J. DEMEESTERE, Robert MIKULÍK (203 Czech Republic, guarantor, belonging to the institution), P. VANACKER, J. E. SIEGLER, J. KORV, J. BILLER, C. W. LIANG, N. S. SANGHA, A. M. ZHA, A. L. CZAP, C. A. HOLMSTEDT, T. N. TURAN, G. NTAIOS, K. MALHOTRA, A. TAYAL, A. LOOCHTAN, A. RANTA, E. A. MISTRY, A. W. ALEXANDROV, D. Y. HUANG, S. YAGHI, E. RAZ, S. A. SHETH, M. H. MOHAMMADEN, M. FRANKEL, E. G. B. LAMOU, H. M. AREF, A. ELBASSIOUNY, F. HASSAN, T. MENECIE, W. MUSTAFA, H. M. SHOKRI, T. ROUSHDY, F. S. SARFO, T. O. ALABI, B. ARABAMBI, E. O. NWAZOR, T. A. SUNMONU, K. WAHAB, J. YARIA, H. H. MOHAMMED, P. B. ADEBAYO, A. D. RIAHI and Sassi S. BEN

Edition

Neurology, Philadelphia, LIPPINCOTT WILLIAMS & WILKINS, 2021, 0028-3878

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30210 Clinical neurology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 11.800

RIV identification code

RIV/00216224:14110/21:00122752

Organization unit

Faculty of Medicine

UT WoS

000702399700021

Keywords in English

COVID-19; Stroke Care; IV Thrombolysis

Tags

Tags

International impact, Reviewed
Změněno: 8/2/2022 10:30, Mgr. Tereza Miškechová

Abstract

V originále

Objective To measure the global impact of COVID-19 pandemic on volumes of IV thrombolysis (IVT), IVT transfers, and stroke hospitalizations over 4 months at the height of the pandemic (March 1 to June 30, 2020) compared with 2 control 4-month periods. Methods We conducted a cross-sectional, observational, retrospective study across 6 continents, 70 countries, and 457 stroke centers. Diagnoses were identified by their ICD-10 codes or classifications in stroke databases. Results There were 91,373 stroke admissions in the 4 months immediately before compared to 80,894 admissions during the pandemic months, representing an 11.5% (95% confidence interval [CI] -11.7 to -11.3, p < 0.0001) decline. There were 13,334 IVT therapies in the 4 months preceding compared to 11,570 procedures during the pandemic, representing a 13.2% (95% CI -13.8 to -12.7, p < 0.0001) drop. Interfacility IVT transfers decreased from 1,337 to 1,178, or an 11.9% decrease (95% CI -13.7 to -10.3, p = 0.001). Recovery of stroke hospitalization volume (9.5%, 95% CI 9.2-9.8, p < 0.0001) was noted over the 2 later (May, June) vs the 2 earlier (March, April) pandemic months. There was a 1.48% stroke rate across 119,967 COVID-19 hospitalizations. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was noted in 3.3% (1,722/52,026) of all stroke admissions. Conclusions The COVID-19 pandemic was associated with a global decline in the volume of stroke hospitalizations, IVT, and interfacility IVT transfers. Primary stroke centers and centers with higher COVID-19 inpatient volumes experienced steeper declines. Recovery of stroke hospitalization was noted in the later pandemic months.

Links

90128, large research infrastructures
Name: CZECRIN III